Incorporated in 1990, Strides Arcolab is a first generation, pharmaceutical company headquartered in Bangalore, India. With business interests in differentiated pharma generics, branded generics, and biopharma, Strides Acrolab Limited is a valued player in the global healthcare industry.
With world-class manufacturing operations at 5 sites, an innovative R&D hub in Bangalore and a strong commercial platform to market branded and commodity generics globally, Strides Acrolab Limited is well positioned to meet the growing demands and challenges in both developed and emerging pharmaceutical markets.
The core competence is in the development and manufacture of niche and technically complex pharmaceutical products. Strides Acrolab Limited is also among the world's largest soft gelatin capsule manufacturers.
The consistent commitment and focus on quality has provided us significant competitive advantage in a rapidly evolving regulatory landscape.
The Quality interventions supported by an IT-driven platform have enabled the implementation of advanced quality standards across manufacturing locations.
Pharma Generics
The core generic pharma business of Strides is led by IP-driven product licensing and marketing and distribution partnerships across the globe. Strides Acrolab Limited has leveraged the expertise in niche, difficult-to-develop and manufacture products to emerge as a preferred provider of solutions to global pharma majors. Strides has created an exhaustive pipeline of generics across varied formats and domains including oral dosage forms and topicals. We are one among the leading players worldwide in soft gel capsules.
Branded Generics
In Emerging Markets, Strides' ambition is to be a highly regarded Regional player known for marketing high-quality, locally relevant generic products. To support the strategy of local relevance and affordable pricing, the products are typically supplied out of a regional manufacturing hub. The generics are branded so that doctors and patients can recognise and recollect quality products from the Strides stable.
India (South Asian Region) and Africa are two of the most established branded generics businesses, where Strides Acrolab Limited has regional manufacturing, solid brands and strong direct sales presence in key markets. Plans are under way to enter Russia/CIS and the MENA/Turkey regions with business localisation strategies.
Institutional Business
As one of the largest Indian suppliers of drugs in the Anti-Retroviral and Anti-Malaria segments, Strides is at the fore-front in the fight against these global pandemics. Strides is an approved supplier to Institutionally-funded aid projects and Global Procurement Agencies like UNITAID, Global Drug Facility (GDF), PEPFAR (The US President’s Emergency Plan for AIDS Relief) and Clinton Foundation. The Anti-Retroviral and Anti-Malarial drugs are supplied to disease-prone regions in Africa, Asia and Latin America and are distributed in more than 65 countries. Strides’ goal is to bring the best treatments at an affordable cost to patients in afflicted countries.